FindTrial
Sign In

Low-molecular-weight heparin

DRUG7 trials

Sponsors

University of Tennessee, Assistance Publique - Hôpitaux de Paris, Ottawa Hospital Research Institute, University of Roma La Sapienza, Capital Medical University

Conditions

Antiphospholipid Syndrome in PregnancyAspirinCoronavirus Disease (COVID)19Deep Venous ThrombosisLow Molecular Weight HeparinNeoplasmNeoplasmsPostpartum Period

Early Phase 1

AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
TerminatedNCT03100123
Ottawa Hospital Research InstituteAntiphospholipid Syndrome in Pregnancy, Pregnancy Loss
Start: 2017-11-06End: 2019-10-07Updated: 2020-04-08

Phase 1

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
CompletedNCT03282643
Capital Medical UniversityNeoplasms
Start: 2016-02-16End: 2019-04-01Updated: 2019-04-16

Phase 3

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban
CompletedNCT02746185
Assistance Publique - Hôpitaux de ParisNeoplasm, Venous Thromboembolism
Start: 2016-09-30End: 2018-04-25Updated: 2018-08-13
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Not yet recruitingNCT06494878
University of CalgaryAspirin, Low Molecular Weight Heparin, Postpartum Period +1
Start: 2025-04-30End: 2030-12-31Target: 8805Updated: 2025-03-03

Phase 4

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia
NCT04584580
Ain Shams UniversityCoronavirus Disease (COVID)19
Start: 2020-08-01End: 2020-12-31Target: 50Updated: 2020-10-14

Unknown Phase

Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
NCT01029821
University of TennesseeDeep Venous Thrombosis
Start: 2010-02-28End: 2013-12-31Target: 100Updated: 2011-06-16
Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards
NCT03157843
University of Roma La SapienzaDeep Venous Thrombosis, Venous Thromboembolism
Start: 2015-02-28End: 2018-01-31Target: 1000Updated: 2017-05-17

Related Papers

Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications.
2022-11-309 citations
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial.
2021-10-08103 citations
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study
Thrombosis and Haemostasis2021-09-1756 citations
Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients.
2019-05-018 citations
COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study.
2018-09-0416 citations